StockData

Microchip Technology vs MACOM Technology Solutions

MCHP and MTSI side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MCHP and MTSI compare

Microchip Technology is the larger company, worth 2.3 times as much as MACOM Technology Solutions ($42.0B against $17.9B).

On earnings, MACOM Technology Solutions is cheaper: it trades at 74.9× trailing earnings, against 115× for Microchip Technology.

MACOM Technology Solutions grew revenue faster over the last twelve months (28.4% versus 20.9% for Microchip Technology).

MACOM Technology Solutions keeps more of each dollar of sales as profit, with a net margin of 20.7% compared with 9.3% at Microchip Technology.

Microchip Technology pays a dividend yielding 2.4%; MACOM Technology Solutions does not pay one.

MACOM Technology Solutions scores higher on the StockData Score (13 against 12 for Microchip Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMCHPMTSI
Size and price
Market cap$42.0B$17.9B
Share price$77.34$234.39
Change, 1 year23.7%53.5%
Change, 5 years−9.8%219%
Beta (5Y)1.671.48
Employees18K2,000
StockData Score
Total score1213 (better)
Valuation score00
Growth score33
Performance score25 (better)
Health score45 (better)
Dividend score3 (better)0
Valuation
P/E115×74.9× (better)
P/S8.2× (better)15.4×
P/B6.5× (better)11.6×
EV/EBITDA32.0× (better)66.9×
P/FCF37.8× (better)87.7×
FCF yield2.6% (better)1.1%
Fair value$33.00$123.70
Margin of safety−134%−89.5% (better)
Growth
Revenue growth (TTM)20.9%28.4% (better)
Revenue growth, 5Y average−2.8%12.8% (better)
EPS growth, 5Y average−19.5%–
Profitability
Gross margin60.2% (better)56.5%
Operating margin15.5%18.1% (better)
Net margin9.3%20.7% (better)
FCF margin21.7% (better)17.5%
Return on equity7.2%17.2% (better)
Return on invested capital5.6%15.8% (better)
Financial health
Debt / equity0.830.22 (better)
Net debt / EBITDA3.46 (better)−1.23
Interest coverage3.7×–
Current ratio1.922.34 (better)
Altman Z-score4.2818.94 (better)
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield2.4%–
Payout ratio206%–
Years of dividend growth17–
Dividend growth, 5Y average19.5%–
Buyback yield−0.15%–
Shareholder yield2.2% (better)0.00%
Ownership
Held by institutions100%95.9%
Held by insiders2.0%6.7%
Insider net buying, 12 months−$71.1M (better)−$320M
Superinvestors holding2 (better)1
Short interest, % of float–4.8%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.